DNA methylation modules in airway smooth muscle are associated with asthma severity

por Perry, Mark M., Lavender, Paul, Kuo, Chih-hsi Scott, Galea, Francesca, Michaeloudes, Charalambos, Flanagan, James M., Fan Chung, Kian, Adcock, Ian M.
Publicado 2018

Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study

por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng
Publicado 2021

Comparison of Different Tyrosine Kinase Inhibitors for Treatment of Poor Performance Status Patients with EGFR-Mutated Lung Adenocarcinoma

por Wu, Chiao-En, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Chang, John Wen-Cheng
Publicado 2022

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI

por Chang, John Wen-Cheng, Huang, Chen-Yang, Fang, Yueh-Fu, Chang, Ching-Fu, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Hsu, Ping-Chih, Wu, Chiao-En
Publicado 2022

Epidermal growth factor receptor tyrosine kinase inhibitors for de novo T790M mutation: A retrospective study of 44 patients

por Chang, John Wen‐Cheng, Huang, Chen‐Yang, Fang, Yueh‐Fu, Chang, Ching‐Fu, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

Sequential treatment in advanced non–small cell lung cancer harboring EGFR mutations

por Hsu, Ping-Chih, Chang, John Wen-Cheng, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Fang, Yueh-Fu, Wu, Chiao-En
Publicado 2022

Epidermal growth factor receptor tyrosine kinase inhibitors for non‐small cell lung cancer harboring uncommon EGFR mutations: Real‐world data from Taiwan

por Chang, John Wen‐Cheng, Huang, Chen‐Yang, Fang, Yueh‐Fu, Chang, Ching‐Fu, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer

por Chang, John Wen‐Cheng, Chang, Ching‐Fu, Huang, Chen‐Yang, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Fang, Yueh‐Fu, Hsu, Ping‐Chih, Wu, Chiao‐En
Publicado 2022

Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR ‐mutated NSCLC treated with afatinib

por Wu, Chen‐Te, Hsu, Ping‐Chih, Chang, John Wen‐Cheng, Chang, Ching‐Fu, Huang, Chen‐Yang, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott, Fang, Yueh‐Fu, Wu, Chiao‐En
Publicado 2023

Impact of T790M Mutation Status on Later-Line Osimertinib Treatment in Non-Small Cell Lung Cancer Patients

por Tang, Yan-Jei, Chang, John Wen-Cheng, Chang, Ching-Fu, Huang, Chen-Yang, Yang, Cheng-Ta, Kuo, Chih-Hsi Scott, Fang, Yueh-Fu, Hsu, Ping-Chih, Wu, Chiao-En
Publicado 2022

Comparison of a combination of chemotherapy and immune checkpoint inhibitors and immune checkpoint inhibitors alone for the treatment of advanced and metastatic non‐small cell lung...

por Kuo, Chih‐Hsi Scott, Wang, Chin‐Chou, Huang, Yu‐Chen, Pavlidis, Stelios, Liu, Chien‐Ying, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Wang, Chih‐Liang, Guo, Yi‐Ke, Yang, Cheng‐Ta
Publicado 2019

A retrospective study of alectinib versus ceritinib in patients with advanced non–small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed

por Kuo, Chih-Hsi Scott, Tung, Pi-Hung, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Chang, John Wen-Cheng, Liu, Chien-Ying, Chung, Fu-Tsai, Fang, Yueh-Fu, Guo, Yi-Ke, Yang, Cheng-Ta
Publicado 2021

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab

por Ko, How-Wen, Chiu, Chi-Tsun, Wang, Chih-Liang, Yang, Tsung-Ying, Liu, Chien-Ying, Yu, Chih-Teng, Tseng, Li-Chuan, Kuo, Chih-Hsi Scott, Wang, Chin-Chou, Yang, Muh-Hwa, Yang, Cheng-Ta
Publicado 2022

Front‐line treatment of ceritinib improves efficacy over crizotinib for Asian patients with anaplastic lymphoma kinase fusion NSCLC: The role of systemic progression control

por Huang, Shih‐Hao, Huang, Allen Chung‐Cheng, Wang, Chin‐Chou, Chang, Wen‐Chen, Liu, Chien‐Ying, Pavlidis, Stelios, Ko, Ho‐Wen, Chung, Fu‐Tsai, Hsu, Ping‐Chih, Guo, Yi‐Ke, Kuo, Chih‐Hsi Scott, Yang, Cheng‐Ta
Publicado 2019

Cardiorespiratory coupling is associated with exercise capacity in patients with chronic obstructive pulmonary disease

por Huang, Yu-Chen, Lin, Ting-Yu, Wu, Hau-Tieng, Chang, Po-Jui, Lo, Chun-Yu, Wang, Tsai-Yu, Kuo, Chih-Hsi Scott, Lin, Shu-Min, Chung, Fu-Tsai, Lin, Horng-Chyuan, Hsieh, Meng-Heng, Lo, Yu-Lun
Publicado 2021

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

por Huang, Allen Chung-Cheng, Huang, Chi-Hsien, Ju, Jia-Shiuan, Chiu, Tzu-Hsuan, Tung, Pi-Hung, Wang, Chin-Chou, Liu, Chien-Ying, Chung, Fu-Tsai, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2021

Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation

por Kuo, Chih-Hsi Scott, Chiu, Tzu-Hsuan, Tung, Pi-Hung, Huang, Chi-Hsien, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Ko, Ho-Wen, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Yang, Cheng-Ta
Publicado 2022

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

por Chiu, Tzu-Hsuan, Tung, Pi-Hung, Huang, Chi-Hsien, Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Wang, Chin-Chou, Ko, Ho-Wen, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2022

Impact of prolonged and early bevacizumab treatment on the overall survival of EGFR‐mutant and EGFR‐wild type nonsquamous non‐small cell lung cancer

por Huang, Yu‐Chen, Shen, Shih‐Min, Liu, Chien‐Ying, Pavlidis, Stelios, Wang, Chih‐Liang, Ko, How‐Wen, Chung, Fu‐Tsai, Lin, Tin‐Yu, Feng, Po‐Hao, Lee, Kang‐Yun, Guo, Yi‐Ke, Yang, Cheng‐Ta, Kuo, Chih‐Hsi Scott
Publicado 2018

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

por Ju, Jia-Shiuan, Huang, Allen Chung-Cheng, Tung, Pi-Hung, Huang, Chi-Hsien, Chiu, Tzu-Hsuan, Wang, Chin-Chou, Ko, How-Wen, Chung, Fu-Tsai, Hsu, Ping-Chih, Fang, Yueh-Fu, Guo, Yi-Ke, Kuo, Chih-Hsi Scott, Yang, Cheng-Ta
Publicado 2023